Literature DB >> 9661569

Tramadol reduces the sweating, vasoconstriction, and shivering thresholds.

J L De Witte1, J S Kim, D I Sessler, H Bastanmehr, A R Bjorksten.   

Abstract

UNLABELLED: The analgesic tramadol inhibits the neuronal reuptake of norepinephrine and 5-hydroxytryptamine, facilitates 5-hydroxytryptamine release, and activates mu-opioid receptors. Each of these actions is likely to influence thermoregulatory control. We therefore tested the hypothesis that tramadol inhibits thermoregulatory control. Eight volunteers were evaluated on four study days, on which they received no drugs, tramadol 125 mg, tramadol 250 mg, and tramadol 250 mg with naloxone, respectively. Skin and core temperatures were gradually increased until sweating was observed and then decreased until vasoconstriction and shivering were detected. The core temperature triggering each response defined its threshold. Tramadol decreased the sweating threshold by -1.03 +/- 0.67 degrees C microgram-1.mL (r2 = 0.90 +/- 0.12). Tramadol also decreased the vasoconstriction threshold by -3.0 +/- 4.0 degrees C microgram-1.mL (r2 = 0.94 +/- 0.98) and the shivering threshold by -4.2 +/- 4.0 degrees C microgram-1.mL(r2 = 0.98 +/- 0.98). The sweating to vasoconstriction interthreshold range nearly doubled from 0.3 +/- 0.4 degree C to 0.7 +/- 0.6 degree C during the administration of large-dose tramadol (P = 0.04). The addition of naloxone only partially reversed the thermoregulatory effects of tramadol. The thermoregulatory effects of tramadol thus most resemble those of midazolam, another drug that slightly decreases the thresholds triggering all three major autonomic thermoregulatory defenses. In this respect, both drugs reduce the "setpoint" rather than produce a generalized impairment of thermoregulatory control. Nonetheless, tramadol nearly doubled the interthreshold range at a concentration near 200 ng/mL. This indicates that tramadol slightly decreases the precision of thermoregulatory control in addition to reducing the setpoint. IMPLICATIONS: The authors evaluated the effects of the analgesic tramadol on the three major thermoregulatory responses: sweating, vasoconstriction, and shivering. Tramadol had only slight thermoregulatory effects. Its use is thus unlikely to provoke hypothermia or to facilitate fever.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661569     DOI: 10.1097/00000539-199807000-00036

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

Review 1.  Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?

Authors:  H Bart van der Worp; Malcolm R Macleod; Rainer Kollmar
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

Review 2.  Physiology and clinical relevance of induced hypothermia.

Authors:  Anthony G Doufas; Daniel I Sessler
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 3.  Tramadol: a review of its use in perioperative pain.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 4.  Ondansetron does not reduce the shivering threshold in healthy volunteers.

Authors:  R Komatsu; M Orhan-Sungur; J In; T Podranski; T Bouillon; R Lauber; S Rohrbach; D Sessler
Journal:  Br J Anaesth       Date:  2006-05-04       Impact factor: 9.166

Review 5.  Postanaesthetic shivering: epidemiology, pathophysiology, and approaches to prevention and management.

Authors:  P Alfonsi
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Efficacy of Tramadol as a Sole Analgesic for Postoperative Pain in Male and Female Mice.

Authors:  A Marissa Wolfe; Lucy H Kennedy; Jane J Na; Jean A Nemzek-Hamlin
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-07       Impact factor: 1.232

7.  Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects.

Authors:  Pascal Alfonsi; Frederic Adam; Andrea Passard; Bruno Guignard; Daniel I Sessler; Marcel Chauvin
Journal:  Anesthesiology       Date:  2004-01       Impact factor: 7.892

8.  Reduction in the incidence of shivering with perioperative dexmedetomidine: A randomized prospective study.

Authors:  Sukhminder Jit Singh Bajwa; Sachin Gupta; Jasbir Kaur; Amarjit Singh; Ss Parmar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01

9.  Doxapram only slightly reduces the shivering threshold in healthy volunteers.

Authors:  Ryu Komatsu; Papiya Sengupta; Grigory Cherynak; Anupama Wadhwa; Daniel I Sessler; Jin Liu; Harrell E Hurst; Rainer Lenhardt
Journal:  Anesth Analg       Date:  2005-11       Impact factor: 6.627

10.  Nefopam for the prevention of perioperative shivering: a meta-analysis of randomized controlled trials.

Authors:  Meng Lv; Xuetao Wang; Wendong Qu; Mengjie Liu; Yuelan Wang
Journal:  BMC Anesthesiol       Date:  2015-06-09       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.